Increased risk of end-stage kidney disease in patients with chronic kidney disease and heart failure with reduced ejection fraction
Cardiorenal Medicine · 15.07.2024
DOI: 10.1159/000540121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiorenal Medicine, online erschienen am 15.07.2024. Verfasst von Saif Al-Chalabi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Kidney Failure, Chronic, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Introduction
The prevalence of heart failure (HF) is more common in people with advanced non-dialysis chronic kidney disease (ND-CKD). It is well known that HF with reduced ejection fraction (HFrEF) is associated with a higher risk of mortality in people with ND-CKD compared to the general population. However, the impact of HFrEF on progression into end-stage kidney disease (ESKD) is not well studied. Our study aimed to examine the independent association of HFrEF on progression to ESKD after correcting for confounding factors using two methods of propensity scoring.
Methods
This study used data from the Salford Kidney Study, a longitudinal study which has recruited more than 3000 patients with ND-CKD since 2002. Patients without a history of HF during the recruitment questionnaire were included in the control group. Patients with a reported history of HF and echo showing left ventricular ejection fraction <40% at enrolment were included in the HFrEF group. Two propensity score methods were used to attenuate the effects of confounding factors between the two groups – propensity score matching (PSM) and inverse probability weighting (IPW). Univariate and multivariate Cox regression analyses were performed.
Results
A total of 2383 patients were included in the analysis. Patients with HFrEF had significantly higher median age and a higher percentage of male gender compared to patients with no HF (72.5 vs 66.6 years and 71.8% vs 61.1% respectively). Univariate and 5 models of multivariate Cox regression analysis showed that HFrEF in people with CKD was a strong predictor for a higher incidence of ESKD (model 5: HR 1.38; 95% CI = 1.01-1.90; p = 0.044). The association between HFrEF and the risk of ESKD remained significant after using the PSM and the IPW methods.
Conclusion
Patients with concomitant advanced ND-CKD and prevalent HFrEF were found to have a higher risk of ESKD when compared to patients with no HF. This risk persists despite the adjustment of confounding factors using PSM and IPW.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Renal Medicine, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
- Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Portsmouth Hospital NHS Foundation Trust, Portsmouth, UK.
- Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, UK.
Zitieren
APA
Al-Chalabi, S., Poulose, M., Rengarajan, S., Kalra, P. R., Green, D., Chinnadurai, R., Sinha, S., & Kalra, P. A. (2024). Increased risk of end-stage kidney disease in patients with chronic kidney disease and heart failure with reduced ejection fraction. Cardiorenal Medicine. https://doi.org/10.1159/000540121
Vancouver
Al-Chalabi S, Poulose M, Rengarajan S, Kalra PR, Green D, Chinnadurai R, et al. Increased risk of end-stage kidney disease in patients with chronic kidney disease and heart failure with reduced ejection fraction. Cardiorenal Medicine. 2024. doi:10.1159/000540121
BibTeX
@article{AlChalabi2024,
author = {Al-Chalabi, Saif and Poulose, Mathew and Rengarajan, Sharmilee and Kalra, Paul R and Green, Darren and Chinnadurai, Rajkumar and Sinha, Smeeta and Kalra, Philip A},
title = {Increased risk of end-stage kidney disease in patients with chronic kidney disease and heart failure with reduced ejection fraction},
journal = {Cardiorenal Medicine},
year = {2024},
doi = {10.1159/000540121}
}
EUVIMED